28 ms·

Sorry if this is considered off-topic, but I mus thave surely missed something about why AstraZeneca is seemingly the only choice on the vaccine market. I am G

Sorry if this is considered off-topic, but I mus thave surely missed something about why AstraZeneca is seemingly the only choice on the vaccine market. I am German, we developed the Pfizer vaccine, but there is _no_ news about it, it seems like the AZ vaccine is the only option. Is it a case that Pfizer wasn't viable, wasn't used here, or only made lucrative contracts with other countries, or is it being used, quietly without drama because they are fulfilling their obligations, unlike AZ who seems to be in the news every day. I celebrated the success of the scientists (Turkish immigrants) who developed it, after the waves and waves of racism in Germany, having immigrants develop a vaccine helped vindicate some of our nation's political decisions to open the doors and borders, that we do in fact benefit, and, sadly now they seem to be invisible again.

deleted 5y ago
[deleted]
hef19898 5y ago
There are a couple, Moderna, Pfizer/Biontech, Johnson&Johnson, AZ and Curevac (soon to be approved as it seems). AZ is the cheapest one (Oxford has them selling at cost so far) and was seen as the most promising last summer. AZ is getting a shit loaf of bad press, so everything AZ related is "news". All vaccines are effective and working, Pfizer as well as AZ.
detaro 5y ago
What? The Biontech-vaccine is mentioned all the time in news about vaccination progress and vaccine distribution. I really wonder how you could have gotten the impression that it isn't used.
DoingIsLearning 5y ago
I can't remember exact values but my guess is this friction comes from the price point. AZ was negotiated at something like less than 2 euros per shot for EU markets, and the Pfizer contracts varied wildly for different countries but it was negotiated at about 15 euros per shot for EU. With my cynical hat on if you are having to vaccinate millions that order of magnitude difference probably matters. What I haven't seen anyone discuss at the EC level is what would be the maths of just paying premium Israel prices for the Pfizer vaccine? Would the economic benefits of get out of this mess as quickly as possible outweigh the extra euros per shot spent on vaccination. My guess is it would likely pay off but then again I am not a European Commissioner.
- NumberCruncher 5y ago
  I remember the exact values, at least the ones published on public media (German ZDF): The negotiation wasn't about the purchasing prise of a shot, but about the price to "reserve a shot". Germany spent ca. 4€ per capita on "reserving an AZ shot", which adds up to a total spending of ca. 350M€. Just to have a comparison: - Last time I bought a beer in a pub in Munich a paid more than 4€ - Just last week Germany spent 1.7B€ on a Syrian topic, which obviously won't change anything, neither for Syria, nor for Germany - The lockdown - ongoing since November - costs 3 to 4B€ per week The only one acting not like a moron in this situation is AZ: selling the vaccine to whoever pays the highest price. If the German politicians could pay the highest price, but doesn't want to, whose fault is that? Funny fact: a friend of mine gets paid to support German R&D on measuring COVID concentration in the sewers to develop an early-warning-system. He says this money should be used to buy vaccines instead of founding some random R&D.
  - shubb 5y ago
    >> selling the vaccine to whoever pays the highest price It does not appear the AZ are shipping vaccine to customers based on price. We know that Pfizer are, which is why Israel has been able to pay them a premium to get vaccines first. Rather, AZ appear to have set up manufacturing dedicated to particular contracts - for instance separate manufacturing in the EU, manufacturing in the UK, manufacturing in the US, and manufacturing in Latin America. They seem to have written contracts that say 'you get what your dedicated manufacturing produces'. The dispute between the EU and AZ is about whether the UK counts as being in the EU - in my opinion AZ appear to have taken money from the UK to build factories there, included those factories in the EU's contracted dedicated manufacturing when they should not have, and then refused to give the EU the vaccines from these factories. This became relevant because AZ manufacturing yields are lower than expected - less vaccine than expected is being produced for a given amount of manufacturing capacity - so the bugs in their contractual arrangements have become visible. So, I agree that AZ screwed up, but I disagree with your model of why.
    - NumberCruncher 5y ago
rn1d 5y ago
The main problem with the Pfizer vaccine is that there is not enough of it. The government of my country gladly orders any Pfizer doses that are offered, but it's not enough. People here generally favor the Pfizer vaccine over the AstraZeneca vaccine, given all the bad press of the latter. Pfizer is very well known and desirable, that's not the problem. AstraZeneca on the other hand promised plentiful quantities, and my country made plans based on those promises, but AstraZeneca failed to deliver. I guess the EU feels screwed over.
ketzu 5y ago
I am not sure where you currently are, so maybe I misunderstand the question. Sorry if that's the case. > there is _no_ news about it There is regular news about Biontech/Pfitzer in Germany. Including additional deliveries based on eu negotiations [1] and it needing yearly refreshments [2]. Further, the vaccine distribution in germany is like this [3]: Biontech 18mio AZ 6mio Moderna 1.8mio [1] https://ec.europa.eu/commission/presscorner/detail/de/statement_21_1202 https://ec.europa.eu/commission/presscorner/detail/de/statem... [2] https://www.n-tv.de/panorama/Biontech-braucht-wohl-jaehrliche-Auffrischung-article22493845.html https://www.n-tv.de/panorama/Biontech-braucht-wohl-jaehrlich... [3] https://impfdashboard.de https://impfdashboard.de
zpeti 5y ago
Turkish immigrants were welcomed into the country, selectively, with a planned system and for job vacancies. Today’s immigrants are illegally crossing borders and refusing to register at the first non-hostile country. They are not using official channels, or even legal systems. I’d just like to point out that difference since you bought the racism card into the debate competely unnecessarily.
deleted 5y ago
[deleted]
rsynnott 5y ago
Eh? Most vaccines being used in Germany, and everywhere else in Europe, are pfizer/biontec. AZ accounts for maybe 25% of supply and dropping.

deleted 5y ago

[deleted]

hef19898 5y ago

There are a couple, Moderna, Pfizer/Biontech, Johnson&Johnson, AZ and Curevac (soon to be approved as it seems). AZ is the cheapest one (Oxford has them selling at cost so far) and was seen as the most promising last summer. AZ is getting a shit loaf of bad press, so everything AZ related is "news". All vaccines are effective and working, Pfizer as well as AZ.

detaro 5y ago

What? The Biontech-vaccine is mentioned all the time in news about vaccination progress and vaccine distribution. I really wonder how you could have gotten the impression that it isn't used.

DoingIsLearning 5y ago

I can't remember exact values but my guess is this friction comes from the price point. AZ was negotiated at something like less than 2 euros per shot for EU markets, and the Pfizer contracts varied wildly for different countries but it was negotiated at about 15 euros per shot for EU. With my cynical hat on if you are having to vaccinate millions that order of magnitude difference probably matters. What I haven't seen anyone discuss at the EC level is what would be the maths of just paying premium Israel prices for the Pfizer vaccine? Would the economic benefits of get out of this mess as quickly as possible outweigh the extra euros per shot spent on vaccination. My guess is it would likely pay off but then again I am not a European Commissioner.

NumberCruncher 5y ago
I remember the exact values, at least the ones published on public media (German ZDF): The negotiation wasn't about the purchasing prise of a shot, but about the price to "reserve a shot". Germany spent ca. 4€ per capita on "reserving an AZ shot", which adds up to a total spending of ca. 350M€. Just to have a comparison: - Last time I bought a beer in a pub in Munich a paid more than 4€ - Just last week Germany spent 1.7B€ on a Syrian topic, which obviously won't change anything, neither for Syria, nor for Germany - The lockdown - ongoing since November - costs 3 to 4B€ per week The only one acting not like a moron in this situation is AZ: selling the vaccine to whoever pays the highest price. If the German politicians could pay the highest price, but doesn't want to, whose fault is that? Funny fact: a friend of mine gets paid to support German R&D on measuring COVID concentration in the sewers to develop an early-warning-system. He says this money should be used to buy vaccines instead of founding some random R&D.
- shubb 5y ago
  >> selling the vaccine to whoever pays the highest price It does not appear the AZ are shipping vaccine to customers based on price. We know that Pfizer are, which is why Israel has been able to pay them a premium to get vaccines first. Rather, AZ appear to have set up manufacturing dedicated to particular contracts - for instance separate manufacturing in the EU, manufacturing in the UK, manufacturing in the US, and manufacturing in Latin America. They seem to have written contracts that say 'you get what your dedicated manufacturing produces'. The dispute between the EU and AZ is about whether the UK counts as being in the EU - in my opinion AZ appear to have taken money from the UK to build factories there, included those factories in the EU's contracted dedicated manufacturing when they should not have, and then refused to give the EU the vaccines from these factories. This became relevant because AZ manufacturing yields are lower than expected - less vaccine than expected is being produced for a given amount of manufacturing capacity - so the bugs in their contractual arrangements have become visible. So, I agree that AZ screwed up, but I disagree with your model of why.
  - NumberCruncher 5y ago

rn1d 5y ago

The main problem with the Pfizer vaccine is that there is not enough of it. The government of my country gladly orders any Pfizer doses that are offered, but it's not enough. People here generally favor the Pfizer vaccine over the AstraZeneca vaccine, given all the bad press of the latter. Pfizer is very well known and desirable, that's not the problem. AstraZeneca on the other hand promised plentiful quantities, and my country made plans based on those promises, but AstraZeneca failed to deliver. I guess the EU feels screwed over.

ketzu 5y ago

I am not sure where you currently are, so maybe I misunderstand the question. Sorry if that's the case. > there is _no_ news about it There is regular news about Biontech/Pfitzer in Germany. Including additional deliveries based on eu negotiations [1] and it needing yearly refreshments [2]. Further, the vaccine distribution in germany is like this [3]: Biontech 18mio AZ 6mio Moderna 1.8mio [1] https://ec.europa.eu/commission/presscorner/detail/de/statement_21_1202 https://ec.europa.eu/commission/presscorner/detail/de/statem... [2] https://www.n-tv.de/panorama/Biontech-braucht-wohl-jaehrliche-Auffrischung-article22493845.html https://www.n-tv.de/panorama/Biontech-braucht-wohl-jaehrlich... [3] https://impfdashboard.de https://impfdashboard.de

zpeti 5y ago

Turkish immigrants were welcomed into the country, selectively, with a planned system and for job vacancies. Today’s immigrants are illegally crossing borders and refusing to register at the first non-hostile country. They are not using official channels, or even legal systems. I’d just like to point out that difference since you bought the racism card into the debate competely unnecessarily.

deleted 5y ago

[deleted]

rsynnott 5y ago

Eh? Most vaccines being used in Germany, and everywhere else in Europe, are pfizer/biontec. AZ accounts for maybe 25% of supply and dropping.